TTD | Drug: D08ZCC

Drug General Information
Drug ID	D08ZCC
Former ID	DIB013327
Drug Name	MTC-896
Synonyms	MC-5 antagonists (dermatological disease), Mimetica
Indication	Seborrhea [ICD10:L21]		Phase 2	[525128]
Company	Mimetica Pty Ltd
Target and Pathway
Target(s)	Melanocortin MC5 receptor	Target Info	Antagonist	[550319]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Peptide ligand-binding receptors
Reactome	G alpha (s) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 525128	ClinicalTrials.gov (NCT02395549) A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris. U.S. National Institutes of Health.
Ref 550319	Clinical pipeline report, company report or official report of Avarx.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information